• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组和转录组分析揭示黑色素瘤演进过程中关键信号通路的逐渐破坏。

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.

机构信息

University of California San Francisco, Department of Dermatology, San Francisco, CA, USA; University of California San Francisco, Helen Diller Comprehensive Cancer Center, San Francisco, CA, USA.

University of California San Francisco, Department of Pathology, San Francisco, CA, USA.

出版信息

Cancer Cell. 2018 Jul 9;34(1):45-55.e4. doi: 10.1016/j.ccell.2018.06.005.

DOI:10.1016/j.ccell.2018.06.005
PMID:29990500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6319271/
Abstract

We elucidated genomic and transcriptomic changes that accompany the evolution of melanoma from pre-malignant lesions by sequencing DNA and RNA from primary melanomas and their adjacent precursors, as well as matched primary tumors and regional metastases. In total, we analyzed 230 histopathologically distinct areas of melanocytic neoplasia from 82 patients. Somatic alterations sequentially induced mitogen-activated protein kinase (MAPK) pathway activation, upregulation of telomerase, modulation of the chromatin landscape, G1/S checkpoint override, ramp-up of MAPK signaling, disruption of the p53 pathway, and activation of the PI3K pathway; no mutations were specifically associated with metastatic progression, as these pathways were perturbed during the evolution of primary melanomas. UV radiation-induced point mutations steadily increased until melanoma invasion, at which point copy-number alterations also became prevalent.

摘要

我们通过对来自 82 名患者的原发性黑素瘤及其相邻前体,以及匹配的原发性肿瘤和区域转移瘤的 DNA 和 RNA 进行测序,阐明了伴随黑色素瘤从癌前病变演变而来的基因组和转录组变化。总的来说,我们分析了 230 个来自 82 名患者的具有组织病理学差异的黑素细胞肿瘤区域。体细胞改变依次诱导丝裂原活化蛋白激酶 (MAPK) 通路激活、端粒酶上调、染色质景观调节、G1/S 检查点失控、MAPK 信号上调、p53 通路失活以及 PI3K 通路激活;没有特定的突变与转移进展相关,因为这些通路在原发性黑素瘤的演变过程中受到干扰。紫外线诱导的点突变持续增加,直到黑色素瘤侵袭,此时拷贝数改变也变得普遍。

相似文献

1
Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.基因组和转录组分析揭示黑色素瘤演进过程中关键信号通路的逐渐破坏。
Cancer Cell. 2018 Jul 9;34(1):45-55.e4. doi: 10.1016/j.ccell.2018.06.005.
2
The Genetic Evolution of Melanoma from Precursor Lesions.黑色素瘤从前期病变的遗传进化。
N Engl J Med. 2015 Nov 12;373(20):1926-36. doi: 10.1056/NEJMoa1502583.
3
Molecular and genetic diversity in the metastatic process of melanoma.黑色素瘤转移过程中的分子和遗传多样性。
J Pathol. 2014 May;233(1):39-50. doi: 10.1002/path.4318. Epub 2014 Jan 27.
4
Lack of distinct molecular profile of Primary Dermal Melanoma.原发性皮肤黑素瘤缺乏独特的分子特征。
Hum Pathol. 2020 Dec;106:32-38. doi: 10.1016/j.humpath.2020.09.002. Epub 2020 Sep 15.
5
Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human.与人类正常皮肤向原发性和转移性黑色素瘤转变相关的分子途径激活特征。
Oncotarget. 2016 Jan 5;7(1):656-70. doi: 10.18632/oncotarget.6394.
6
Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals.台湾个体不同类型黑色素瘤中不同的丝裂原活化蛋白激酶(MAPK)和磷脂酰肌醇-3激酶(PI3K)通路突变。
Eur J Dermatol. 2018 Aug 1;28(4):509-518. doi: 10.1684/ejd.2018.3359.
7
UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.紫外线诱导的黑色素瘤和非黑色素瘤皮肤癌中的分子信号差异
Adv Exp Med Biol. 2017;996:27-40. doi: 10.1007/978-3-319-56017-5_3.
8
BET inhibitor suppresses melanoma progression the noncanonical NF-κB/SPP1 pathway.BET 抑制剂抑制黑色素瘤进展的非经典 NF-κB/SPP1 通路。
Theranostics. 2020 Sep 15;10(25):11428-11443. doi: 10.7150/thno.47432. eCollection 2020.
9
IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.原发肿瘤细胞的 IL-10 表达与黑色素瘤从放射性生长阶段向垂直生长阶段的进展以及转移能力的发展相关。
Mod Pathol. 2011 Jun;24(6):801-9. doi: 10.1038/modpathol.2011.5. Epub 2011 Feb 11.
10
Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.通过 array 比较基因组杂交揭示 BRAF 和 NRAS 突变原发性黑色素瘤之间明显的遗传差异。
Melanoma Res. 2012 Jun;22(3):202-14. doi: 10.1097/CMR.0b013e328352dbc8.

引用本文的文献

1
Local Recurrence and Survival in Patients With Melanoma In Situ.原位黑色素瘤患者的局部复发与生存情况
JAMA Dermatol. 2025 Sep 3. doi: 10.1001/jamadermatol.2025.3078.
2
Circular RNA circ_0001591 Contributes to Melanoma Cell Migration Through AXL and FRA1 Proteins by Targeting miR-20a-3p and miR-34a-5p.环状RNA circ_0001591通过靶向miR-20a-3p和miR-34a-5p并借助AXL和FRA1蛋白促进黑色素瘤细胞迁移。
Genes (Basel). 2025 Jul 30;16(8):921. doi: 10.3390/genes16080921.
3
Melanoma microsatellites exhibit a metastatic signature by spatial transcriptomics and overexpress mediators of immune evasion.

本文引用的文献

1
Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.CDKN2A 双等位基因缺失通过 BRN2 激活引发黑色素瘤侵袭。
Cancer Cell. 2018 Jul 9;34(1):56-68.e9. doi: 10.1016/j.ccell.2018.05.014.
2
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.组蛋白甲基转移酶 Ezh2 控制肿瘤免疫治疗适应性耐药的机制。
Cell Rep. 2017 Jul 25;20(4):854-867. doi: 10.1016/j.celrep.2017.07.007.
3
From melanocytes to melanomas.从黑素细胞到黑色素瘤。
黑色素瘤微卫星通过空间转录组学呈现转移特征并过表达免疫逃逸介质。
Virchows Arch. 2025 Jul 28. doi: 10.1007/s00428-025-04182-7.
4
MCSP metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization.MCSP转移起始细胞在人类黑色素瘤转移定植早期激活免疫抑制。
Nat Cancer. 2025 May 16. doi: 10.1038/s43018-025-00963-w.
5
The SWI/SNF PBAF complex facilitates REST occupancy at repressive chromatin.SWI/SNF PBAF复合物促进REST在抑制性染色质上的占据。
Mol Cell. 2025 May 1;85(9):1714-1729.e7. doi: 10.1016/j.molcel.2025.03.026. Epub 2025 Apr 18.
6
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.未经治疗的转移性恶性黑色素瘤的蛋白质基因组分析
Cancers (Basel). 2025 Feb 27;17(5):832. doi: 10.3390/cancers17050832.
7
Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma.痣相关黑色素瘤在黑色素瘤患者中的预后价值
Ann Surg Oncol. 2025 May;32(5):3189-3197. doi: 10.1245/s10434-025-16945-2. Epub 2025 Feb 1.
8
Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.神经纤维瘤蛋白1缺失加速葡萄膜和皮内黑色素瘤的肿瘤发生,且致癌性GNAQ可转化雪旺细胞。
Cancer Res Commun. 2025 Feb 1;5(2):209-225. doi: 10.1158/2767-9764.CRC-24-0386.
9
Specific enhancer elements modulate phenotype plasticity and drug resistance in melanoma.特定增强子元件调节黑色素瘤的表型可塑性和耐药性。
bioRxiv. 2024 Dec 17:2024.12.12.628224. doi: 10.1101/2024.12.12.628224.
10
Braf-Mutant Melanomas: Biology and Therapy.BRAF 突变型黑色素瘤:生物学与治疗
Curr Oncol. 2024 Dec 3;31(12):7711-7737. doi: 10.3390/curroncol31120568.
Nat Rev Cancer. 2016 Jun;16(6):345-58. doi: 10.1038/nrc.2016.37. Epub 2016 Apr 29.
4
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.CNVkit:通过靶向DNA测序进行全基因组拷贝数检测与可视化
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873. doi: 10.1371/journal.pcbi.1004873. eCollection 2016 Apr.
5
The Genetic Evolution of Melanoma from Precursor Lesions.黑色素瘤从前期病变的遗传进化。
N Engl J Med. 2015 Nov 12;373(20):1926-36. doi: 10.1056/NEJMoa1502583.
6
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.促纤维增生性黑色素瘤的外显子组测序鉴定出NFKBIE启动子的复发性突变以及丝裂原活化蛋白激酶(MAPK)信号通路中的多种激活突变。
Nat Genet. 2015 Oct;47(10):1194-9. doi: 10.1038/ng.3382. Epub 2015 Sep 7.
7
Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.黑色素瘤的系统发育分析揭示了转移扩散的复杂模式。
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):10995-1000. doi: 10.1073/pnas.1508074112. Epub 2015 Aug 18.
8
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.外显子组测序在暴露于阳光的黑色素瘤中鉴定出神经纤维瘤病1型(NF1)基因和RAS病相关基因的复发性突变。
Nat Genet. 2015 Sep;47(9):996-1002. doi: 10.1038/ng.3361. Epub 2015 Jul 27.
9
Genomic Classification of Cutaneous Melanoma.皮肤黑色素瘤的基因组分类
Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044.
10
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.表观遗传修饰因子 EZH2 通过沉默不同的肿瘤抑制因子来控制黑色素瘤的生长和转移。
Nat Commun. 2015 Jan 22;6:6051. doi: 10.1038/ncomms7051.